核素肝血流动态显象测定HPI方法及临床应用价值  

MEASUREMENT OF HPI IN HEPATIC BLOOD FLOW WITH RADIO ISOTOPE AND CLINICAL APPLICATION

作　　者：马步成[1,2] 王诗雅[1,2] 袁贺云[1,2] 崔霞[1,2] 朱国泓[1,2] 印会河 

机构地区：[1]中日友好医院核医学科 [2]中日友好医院中医肺脾科

出　　处：《中日友好医院学报》1991年第1期28-31,共4页Journal of China-Japan Friendship Hospital

摘　　要：应用^(99m)Tc-植酸钠肝血流动态显象测定各种肝病HPI值,结果:正常人为33.9±4.1(n=7);慢性肝炎、肝硬变患者分别为45.0±5.0(n=19)和52.4±10.5(n=18)。各组之间均有显著差异(P<0.005)。10例慢性肝病患者经中药治疗后HPI值均有不同程度下降。10例肝癌患者肝区HPI或肿瘤局部HPI值均有显著增高,其中1例行肝动脉栓塞治疗后HPI值有明显下降。说明HPI测定有助于判断慢性肝病及肝癌患者的预后和治疗效果,是一有临床应用价值的简便、灵敏的检查方法。The hepatic perfusion index (HPI) was measured in patients with various liver diseases using ^(99m) Tc-phytate, and its clinical significance in relation to the progression of the diseases (normal 33. 9 ± 4.1, chronic heparitis 45. 0 ± 5. 0 and liver cirrhosis 52. 4 ± 10. 5) was discussed. In ten patients with liver cancer, the value of HPI in the region of cancer was apparently increased. After treatment, the values of HPI in ten patients with chronic liver disease and one patient with liver cancer were all decreased. It is a simple and sensitive method in clinical application.

关 键 词：肝灌流指数 ^99m锝-植酸钠 

分 类 号：R[医药卫生]